Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  exam on AUG 8th 




 
Kaplan Qbank USMLE



Author20 Posts
  #1

i took my exam yesterday.
my exam includes 50% IM and Peds, 25% gynec & obs, 10% psychiatry, 15% remaining.
i got only 3 questions on biostatistics.I didn't get any audio-video questions.
My suggestions
Time management is very very important. i left 3 questions over all in my exam bcoz of lack of time,
guys concentrate on OBG they are giving many questions from OBG which we can answer with much confidence when compared to IM. concentrate on bleeding both in gynecology and obs
In psychiatry many questions are on diagnosis and treatment. remember all drugs and there side effects. most of the times they are asking second line of treatment rather than ideal or first line of treatment.
In preventive medicine don't forget to read U.S. Preventive Services Task Force recommendations. read A and B recommendations.
In IM, its a very vast topic. don't expect that u will get everything from kaplan. always remember that they won't test u on facts, they will only test ur logic.i got many questions on topics not in kaplan.But what i felt was we can do them but we need time, which is the main constraint for me.So manage ur time cleverly.
In surgery most of them are on trauma and orthopedics.

toughness of the exam
some questions are very simple, but some are very hard. most of the exam is UW. i got some (4-5) questions from UW question bank.
for me first 4 blocks are good, but after that next 2 bocks are tough. after that next two bocks are like just ok ones.

that's it. that's all about my exam. if u have any queries let me know.

Last but not least. I thank Dr Virgo and Dr Cirus for there posts. They are doing good job. Nice questions and good explanations

  #2

I keep hearing the questions are vague.....what does that mean?

Good Luck with your step 2 score.


  #3

so what else you use besides kaplan and UW?
Its UW concepts from step2 on your test?
what % of your test you can say right now thank you UW


___________________
As a general rule, the better it felt when you said it, the more trouble it's going to get you into.

  #4

Good luck with your score. Did you use FA ? And if you did was it of any help?


  #5

Congratultions, I hope u get a good score ISAgrin

Thanks for ur kind wordssmiling face


  #6

Congratulations for being done with this one. Wish you a high score. Thanks for sharing your experience.smiling face

  #7

i didn't use FA. questions are vague in the sense u can't come to a single answer most of the times.

  #8

i studied kaplan, UW and crush.

  #9

Congratulations! What does it mean A and B recommendations? Perhaps you can provide links? Did you like crush? thanks

  #10

http://www.ahrq.gov/clinic/uspstfix.htm here is the link

  #11

Thanks for sharing!
Best of luck on the scorenod

  #12

Thanks nagi_step1. I know that link, plenty of information. Can you tell me where to find particularly A and B recommendations?

  #13

adverse effects of beta-carotene on smokers have been observed primarily in those taking large supplemental doses.The USPSTF
recommends against the use of
beta-carotene supplements, either alone or in
combination, for the prevention of cancer or
cardiovascular disease.

The USPSTF recommends that women whose
family history is associated with an increased risk
for deleterious mutations in BRCA1 or BRCA2
genes be referred for genetic counseling and
evaluation for BRCA testing

The U.S. Preventive Services Task Force
(USPSTF) recommends against routine use of
tamoxifen or raloxifene for the primary prevention
of breast cancer in women at low or average risk
for breast cancer.Currently, only tamoxifen is approved by the U.S.
Food and Drug Administration (FDA) for the
specific indication of breast cancer
chemoprevention.Raloxifene is approved by the FDA for
preventing and treating osteoporosis

The U.S. Preventive Services Task Force
(USPSTF) recommends screening mammography,
with or without clinical breast examination (CBE),
every 1-2 years for women aged 40 and older

The USPSTF recommends against routinely
screening women older than age 65 for cervical
cancer if they have had adequate recent screening
with normal Pap smears and are not otherwise at
high risk for cervical cancer

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
screen men and women 50 years of age or older for
colorectal cancer

There is no existing evidence that any screening
test, including CA-125, ultrasound, or pelvic
examination, reduces mortality from ovarian cancer.
Furthermore, existing evidence that screening can
detect early-stage ovarian cancer is insufficient to
indicate that this earlier diagnosis will reduce
mortality

The U.S. Preventive Services Task Force
(USPSTF) concludes that the evidence is
insufficient to recommend for or against routine
screening for prostate cancer using prostate specific
antigen (PSA) testing or digital rectal examination
(DRE).

The U.S. Preventive Services Task Force
(USPSTF) recommends one-time screening for
abdominal aortic aneurysm (AAA) by
ultrasonography in men aged 65 to 75 who have
ever smoked

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
discuss aspirin chemoprevention with adults who
are at increased risk for coronary heart disease
(CHD). Discussions with patients should address
both the potential benefits and harms of aspirin
therapy.

The U.S. Preventive Services Task Force
(USPSTF) recommends against routine screening
with resting electrocardiography (ECG), exercise
treadmill test (ETT), or electron-beam
computerized tomography (EBCT) scanning for
coronary calcium for either the presence of severe
coronary artery stenosis (CAS) or the prediction of
coronary heart disease (CHD) events in adults at
low risk for CHD events.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
screen adults aged 18 and older for high blood
pressure.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
routinely screen men aged 35 years and older and
women aged 45 years and older for lipid disorders
and treat abnormal lipids in people who are at
increased risk for coronary heart disease. Rating: A
Recommendation.

The USPSTF recommends that clinicians
routinely screen younger adults (men aged 20 to 35
years and women aged 20 to 45 years) for lipid
disorders if they have other risk factors for coronary
heart disease. (See Clinical Considerations for a
discussion of risk factors.) Rating: B
Recommendation.

The USPSTF makes no recommendation for or
against routine screening for lipid disorders in
younger adults (men aged 20 to 35 years or women
aged 20 to 45 years) in the absence of known risk
factors for coronary heart disease. Rating: C
Recommendation.

The USPSTF recommends that screening for
lipid disorders include measurement of total
cholesterol (TC) and high-density lipoprotein
cholesterol (HDL-C). Rating: B Recommendation.
The USPSTF concludes that the evidence is
insufficient to recommend for or against triglyceride
measurement as a part of routine screening for lipid
disorders. Rating: I Recommendation

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that all pregnant
women be screened for asymptomatic bacteriuria
using urine culture at 12-16 weeks’ gestation.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
routinely screen all sexually active women aged 25
years and younger, and other asymptomatic
women at increased risk for infection, for
chlamydial infection (see Clinical Considerations
for discussion of risk factors).

The USPSTF makes no recommendation for or
against routinely screening asymptomatic low-risk
women in the general population for chlamydial
infection. Rating: C Recommendation.

The USPSTF recommends that clinicians
routinely screen all asymptomatic pregnant women
aged 25 years and younger and others at increased
risk for chlamydial infection (see Clinical
Considerations for discussion of risk factors in
pregnancy). Rating: B Recommendation.

The USPSTF makes no recommendation for or
against routine screening of asymptomatic, low-risk
pregnant women aged 26 years and older for
chlamydial infection. Rating: C Recommendation.

The USPSTF concludes that the evidence is
insufficient to recommend for or against routinely
screening asymptomatic men for chlamydial
infection. Rating: I Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) recommends that clinicians screen all
sexually active women, including those who are
pregnant, for gonorrhea infection if they are at
increased risk for infection (that is, if they are young
or have other individual or population risk factors;
see Clinical Considerations for further discussion of
risk factors). Rating: B Recommendation.

The USPSTF found insufficient evidence to
recommend for or against routine screening for
gonorrhea infection in men at increased risk for
infection (see Clinical Considerations for discussion
of risk factors). Rating: I Recommendation.

The USPSTF recommends against routine
screening for gonorrhea infection in men and
women who are at low risk for infection (see
Clinical Considerations for discussion of risk
factors). Rating: D Recommendation.
The USPSTF found insufficient evidence to
recommend for or against routine screening for
gonorrhea infection in pregnant women who are
not at increased risk for infection (see Clinical
Considerations for discussion of risk factors).
Rating: I Recommendation.
The USPSTF strongly recommends prophylactic
ocular topical medication for all newborns against
gonococcal ophthalmia neonatorum.
Rating: A Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends screening for
hepatitis B virus (HBV) infection in pregnant
women at their first prenatal visit

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
screen for human immunodeficiency virus (HIV)
all adolescents and adults at increased risk for HIV
infection. Rating: A Recommendation.
The USPSTF makes no recommendation for or
against routinely screening for HIV adolescents
and adults who are not at increased risk for HIV
infection. Rating: C Recommendation.
The USPSTF recommends that clinicians screen
all pregnant women for HIV. Rating: A
Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
screen persons at increased risk for syphilis
infection. Rating: A Recommendation.
The USPSTF strongly recommends that
clinicians screen all pregnant women for syphilis
infection. Rating: A Recommendation.
The USPSTF recommends against routine
screening of asymptomatic persons who are not at
increased risk for syphilis infection. Rating: D
Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) recommends screening and behavioral
counseling interventions to reduce alcohol misuse
(go to Clinical Considerations) by adults,
including pregnant women, in primary care
settings. Rating: B Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) strongly recommends that clinicians
screen all adults for tobacco use and provide
tobacco cessation interventions for those who use
tobacco products. Rating: A Recommendation.
The USPSTF strongly recommends that
clinicians screen all pregnant women for tobacco
use and provide augmented pregnancy-tailored
counseling to those who smoke. Rating: A
Recommendation.

The USPSTF recommends screening for type 2
diabetes in adults with hypertension or
hyperlipidemia. Rating: B Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) recommends that women aged 65 and
older be screened routinely for osteoporosis. The
USPSTF recommends that routine screening
begin at age 60 for women at increased risk for
osteoporotic fractures (see Clinical
Considerations for discussion of women at
increased risk). Rating: B Recommendation.

The USPSTF recommends repeated Rh (D)
antibody testing for all unsensitized Rh (D)-
negative women at 24-28 weeks’ gestation, unless
the biological father is known to be Rh (D)-
negative. Rating: B Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) recommends that primary care
clinicians prescribe oral fluoride supplementation
at currently recommended doses to preschool
children older than 6 months of age whose
primary water source is deficient in fluoride.
Rating: B Recommendation.

The U.S. Preventive Services Task Force
(USPSTF) recommends screening to detect
amblyopia, strabismus, and defects in visual acuity
in children younger than age 5 years. Rating: B
Recommendation.



  #14

thanks a lot for the info and wish you a wonderful score nagi_step1 .

GL

  #15

Thank you very much indeed

  #16

thank u very much nagi_step1.good luck on your score.
how is the crush book?and i need some info about pre-test.could any body help me in this regard.

___________________
papa kehte hain bada naam karegaa...

  #17

crush is good for last review, i didn't find any advantage with pretest.

  #18

oh,thank u .i,ve been in doubt till now.wink

___________________
papa kehte hain bada naam karegaa...

  #19

Hey Nagi..I Got 300 on nbme 1 which correlates to a score of 162. This was on august 1. Sicne then have been studying usmle world questions again and reading kaplan one more time. To those who have taken the exam..do you think this is sufficient to pass? My exam is on august 29. thanks!

  #20

i advice u to take nbme form 2 on aug 20th. many say that this form is more close to ur final score. concentrate on weak areas in nbme1. If u can get above 400 in nbme 2 then u can go for exam confidently.







You don't have permission to post.




Login or Register to post messages in this topic





















Contact | Leaders | Disclaimer | Privacy

Copyright @ Prep for USMLE. All rights reserved.